List view / Grid view
10 July 2015 | By Victoria White
Fresenius Kabi and Calea have been sentenced for supplying hospitals with defective pre-filled syringes that contributed to the death of a diabetic patient...
9 July 2015 | By Victoria White
Market Access Consultants Curo have received the highest accolade given to British businesses, the Queen’s Award for Enterprise...
9 July 2015 | By Victoria White
Researchers have been studying what happens when different chemotherapy drugs come in contact with the silver coating on catheters with surprising results...
9 July 2015 | By Victoria White
Tillotts Pharma has entered into an agreement for the acquisition of the global rights for Entocort from AstraZeneca, excluding the US...
9 July 2015 | By Victoria White
Teva has launched generic Axert® (almotriptan malate) tablets in the US for the treatment of migraine attacks in adults and adolescents...
9 July 2015 | By Victoria White
The US Food and Drug Administration (FDA) has accepted Aridis Pharmaceuticals’ Investigational New Drug (IND) application for AR-301 (Salvecin)...
9 July 2015 | By Victoria White
Around half of all breast cancer patients could one day benefit from having the cheap and widely-available hormone progesterone added to their treatment...
9 July 2015 | By Victoria White
A trial of has shown up to 86% of patients with psoriasis receiving guselkumab achieved a PGA score of cleared psoriasis or minimal psoriasis at week 16...
8 July 2015 | By Victoria White
Sanofi is to extend its collaboration with Medicines for Malaria Venture (MMV) to jointly develop a new single, fixed-dose combination therapy for malaria...
8 July 2015 | By Victoria White
Arrowhead Research Corporation has received regulatory permission in the UK and New Zealand to proceed with Part B of its Phase 1 study of ARC-AAT...
8 July 2015 | By Victoria White
Lilly’s NSCLC drug, necitumumab, has raised concerns with the FDA after trial data suggested that the drug might increase the likelihood of fatal clots...
8 July 2015 | By Victoria White
AXON Neuronscience's vaccine intended to be a disease modifying drug for Alzheimer’s disease patients has passed a Phase 1 safety trial...
8 July 2015 | By Victoria White
The US Food and Drug Administration (FDA) has approved Novartis' Entresto (sacubitril/valsartan) tablets for the treatment of heart failure with reduced ejection fraction.
8 July 2015 | By Victoria White
Genticel has announced that the independent Data Safety Monitoring Board recommends the continuation, per protocol, of its Phase 2 clinical trial of GTL001...
8 July 2015 | By Victoria White
Eisai’s Fycompa (perampanel), a once-daily epilepsy treatment that inhibits AMPA receptors, launches in the United Kingdom today...
